Bereich
Medizinische Onkologie und Hämatologie
ONKO · Dept. I
Transcription analysis of the genes tcdA-E of the pathogenicity locus of Clostridium difficile
Hundsberger T, Braun V, Weidmann M, Leukel P, Sauerborn M, von Eichel-Streiber C. Transcription analysis of the genes tcdA-E of the pathogenicity locus of Clostridium difficile. European journal of biochemistry / FEBS 1997; 244:735-42.
15.03.1997Transcription analysis of the genes tcdA-E of the pathogenicity locus of Clostridium difficile
15.03.1997European journal of biochemistry / FEBS 1997; 244:735-42
Hundsberger Thomas, Braun V, Weidmann M, Leukel P, Sauerborn M, von Eichel-Streiber C
Musiktherapie als Zugang zu frühesten Prägungen und Störungen
Renz M, Müller C, Petzold H. Musiktherapie als Zugang zu frühesten Prägungen und Störungen. In: Musiktherapie in der klinischen Arbeit. Stuttgart: Gustav Fischer, 1997. S. 175-185.
01.01.1997Musiktherapie als Zugang zu frühesten Prägungen und Störungen
01.01.1997Gustav Fischer
Renz Monika, Müller Christian, Petzold Hilarion G
Urangst - Urvertrauen - Frühstörungen
Renz M, Fitzthum E, Oberegelsbacher D, Storz D. Urangst - Urvertrauen - Frühstörungen. In: Wiener Beiträge zur Musiktherapie. Wien: Edition Praesens, 1997. S. 67-83.
01.01.1997Urangst - Urvertrauen - Frühstörungen
01.01.1997Edition Praesens
Renz Monika, Fitzthum Elena, Oberegelsbacher Dorothea, Storz Dorothee
Dose-response study of ibandronate in the treatment of cancer-associated hypercalcaemia
Ralston S, Tubiana-Hulin M, Huss H, Hagberg H, Rizzoll R, Lichinitser M, Walls J, Thürlimann B, Steinhauer E, Herrmann Z, Thiébaud D, Body J. Dose-response study of ibandronate in the treatment of cancer-associated hypercalcaemia. British journal of cancer 1997; 75:295-300.
01.01.1997Dose-response study of ibandronate in the treatment of cancer-associated hypercalcaemia
01.01.1997British journal of cancer 1997; 75:295-300
Ralston S H, Tubiana-Hulin M, Huss H J, Hagberg H, Rizzoll R, Lichinitser M R, Walls J, Thürlimann Beat, Steinhauer E U, Herrmann Z, Thiébaud D, Body J J
[Paraneoplastic retinopathy in 2 patients with breast carcinoma]
Huober J, Holz F, Schmid H, Nölle B, Bellmann C, Krastel H, Wallwiener D, Bastert G. [Paraneoplastic retinopathy in 2 patients with breast carcinoma]. Zentralblatt für Gynäkologie 1997; 119:278-81.
01.01.1997[Paraneoplastic retinopathy in 2 patients with breast carcinoma]
01.01.1997Zentralblatt für Gynäkologie 1997; 119:278-81
Huober Jens, Holz F G, Schmid H, Nölle B, Bellmann C, Krastel H, Wallwiener D, Bastert G
Allelic imbalance in three distinct regions on chromosome 17q in sporadic breast cancer correlates with prognostic parameters
Hamann U, Costa S, Goette K, Huober J, Solomayer E, Kaufmann M, Bastert G, Komitowski D. Allelic imbalance in three distinct regions on chromosome 17q in sporadic breast cancer correlates with prognostic parameters. The Breast 1997; 6:5.
01.01.1997Allelic imbalance in three distinct regions on chromosome 17q in sporadic breast cancer correlates with prognostic parameters
01.01.1997The Breast 1997; 6:5
Hamann U, Costa SD, Goette K, Huober Jens, Solomayer EF, Kaufmann M, Bastert G, Komitowski D
Post partum Hysterektomie bei 2 Patientinnen mit Placenta percreta
Huober J, Grischke E, Hahn U, Wallwiener D, Bastert G. Post partum Hysterektomie bei 2 Patientinnen mit Placenta percreta. Gynäkolo. prax 1997; 21:685-689.
01.01.1997Post partum Hysterektomie bei 2 Patientinnen mit Placenta percreta
01.01.1997Gynäkolo. prax 1997; 21:685-689
Huober Jens, Grischke E-M, Hahn U, Wallwiener D, Bastert G
Comparative pharmacokinetic and cytotoxic analysis of three different formulations of mitoxantrone in mice
Rentsch K, Horber D, Schwendener R, Wunderli-Allenspach H, Haenseler E. Comparative pharmacokinetic and cytotoxic analysis of three different formulations of mitoxantrone in mice. Br J Cancer 1997; 75:986-992.
01.01.1997Comparative pharmacokinetic and cytotoxic analysis of three different formulations of mitoxantrone in mice
01.01.1997Br J Cancer 1997; 75:986-992
Rentsch K.M., Horber Daniel, Schwendener R., Wunderli-Allenspach H., Haenseler E.
Zwischen Urangst und Urvertrauen
Renz M. Zwischen Urangst und Urvertrauen. PanZeitung. Musik in Beruf, Freizeit, Erziehung und Therapie 1996:14-15.
01.12.1996Zwischen Urangst und Urvertrauen
01.12.1996PanZeitung. Musik in Beruf, Freizeit, Erziehung und Therapie 1996:14-15
Renz Monika
Definition of the single integration site of the pathogenicity locus in Clostridium difficile
Braun V, Hundsberger T, Leukel P, Sauerborn M, von Eichel-Streiber C. Definition of the single integration site of the pathogenicity locus in Clostridium difficile. Gene 1996; 181:29-38.
28.11.1996Definition of the single integration site of the pathogenicity locus in Clostridium difficile
28.11.1996Gene 1996; 181:29-38
Braun V, Hundsberger Thomas, Leukel P, Sauerborn M, von Eichel-Streiber C
[Hormone therapy of metastasizing breast carcinoma]
Hagen M, Thürlimann B. [Hormone therapy of metastasizing breast carcinoma]. Therapeutische Umschau. Revue thérapeutique 1996; 53:820-8.
01.11.1996[Hormone therapy of metastasizing breast carcinoma]
01.11.1996Therapeutische Umschau. Revue thérapeutique 1996; 53:820-8
Hagen M F, Thürlimann Beat
Evidence for multiple sites of interaction between IL-12 and its receptor
Presky D, Minetti L, Gillessen Sommer S, Gubler U, Chizzonite R, Stern A, Gately M. Evidence for multiple sites of interaction between IL-12 and its receptor. Annals of the New York Academy of Sciences 1996; 795:390-3.
31.10.1996Evidence for multiple sites of interaction between IL-12 and its receptor
31.10.1996Annals of the New York Academy of Sciences 1996; 795:390-3
Presky D H, Minetti L J, Gillessen Sommer Silke, Gubler U, Chizzonite R, Stern A S, Gately M K
Interleukin-12 antagonist activity of mouse interleukin-12 p40 homodimer in vitro and in vivo
Gately M, Stern A, Familletti P, Faherty D, Podlaski F, Higgins G, Dwyer C, Wilkinson V, Kolinsky K, Warrier R, Gillessen Sommer S, Connaughton S, Carvajal D, Presky D. Interleukin-12 antagonist activity of mouse interleukin-12 p40 homodimer in vitro and in vivo. Annals of the New York Academy of Sciences 1996; 795:1-12.
31.10.1996Interleukin-12 antagonist activity of mouse interleukin-12 p40 homodimer in vitro and in vivo
31.10.1996Annals of the New York Academy of Sciences 1996; 795:1-12
Gately M K, Stern A S, Familletti P C, Faherty D A, Podlaski F J, Higgins G F, Dwyer C M, Wilkinson V L, Kolinsky K D, Warrier R R, Gillessen Sommer Silke, Connaughton S E, Carvajal D M, Presky D H
Stimulation of human peripheral blood mononuclear cells by zinc and related cations
Wellinghausen N, Driessen C, Rink L. Stimulation of human peripheral blood mononuclear cells by zinc and related cations. Cytokine 1996; 8:767-71.
01.10.1996Stimulation of human peripheral blood mononuclear cells by zinc and related cations
01.10.1996Cytokine 1996; 8:767-71
Wellinghausen N, Driessen Christoph, Rink L
Was die Musik bewirken kann
Renz M. Was die Musik bewirken kann. St. Galler Tagblatt 1996
09.09.1996Was die Musik bewirken kann
09.09.1996St. Galler Tagblatt 1996
Renz Monika
Psychotherapie im Bereich des Sprachlosen
Renz M. Psychotherapie im Bereich des Sprachlosen - Möglichkeiten und Praxis der Musiktherapie. Neue Zürcher Zeitung 1996:66.
17.08.1996Psychotherapie im Bereich des Sprachlosen
17.08.1996Neue Zürcher Zeitung 1996:66
Renz Monika
First-line fadrozole HCI (CGS 16949A) versus tamoxifen in postmenopausal women with advanced breast cancer. Prospective randomised trial of the Swiss Group for Clinical Cancer Research SAKK 20/88
Thürlimann B, Fey M, Senn H, Cavalli F, Jungi W, Goldhirsch A, Castiglione-Gertsch M, Bacchi M, Beretta K, Löhnert T. First-line fadrozole HCI (CGS 16949A) versus tamoxifen in postmenopausal women with advanced breast cancer. Prospective randomised trial of the Swiss Group for Clinical Cancer Research SAKK 20/88. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1996; 7:471-9.
01.07.1996First-line fadrozole HCI (CGS 16949A) versus tamoxifen in postmenopausal women with advanced breast cancer. Prospective randomised trial of the Swiss Group for Clinical Cancer Research SAKK 20/88
01.07.1996Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1996; 7:471-9
Thürlimann Beat, Fey M, Senn H J, Cavalli F, Jungi W F, Goldhirsch A, Castiglione-Gertsch M, Bacchi M, Beretta K, Löhnert T
The changing approach to the treatment of early breast cancer
Thürlimann B, Senn H. The changing approach to the treatment of early breast cancer. The New England journal of medicine 1996; 334:1397-9.
23.05.1996The changing approach to the treatment of early breast cancer
23.05.1996The New England journal of medicine 1996; 334:1397-9
Thürlimann Beat, Senn H J
[Paraneoplastic cerebellar degeneration: case report of a patient with breast carcinoma]
Huober J, Niedermaier N, Drlicek M, Kaufmann M, Hacke W, Bastert G. [Paraneoplastic cerebellar degeneration: case report of a patient with breast carcinoma]. Geburtshilfe und Frauenheilkunde 1996; 56:214-6.
01.04.1996[Paraneoplastic cerebellar degeneration: case report of a patient with breast carcinoma]
01.04.1996Geburtshilfe und Frauenheilkunde 1996; 56:214-6
Huober Jens, Niedermaier N, Drlicek M, Kaufmann M, Hacke W, Bastert G
Causes and treatment of bone pain of malignant origin
Thürlimann B, de Stoutz N. Causes and treatment of bone pain of malignant origin. Drugs 1996; 51:383-98.
01.03.1996Causes and treatment of bone pain of malignant origin
01.03.1996Drugs 1996; 51:383-98
Thürlimann Beat, de Stoutz N D